Search
 
Company

Janssen Biotech, Inc.

20 Case(s) (Last 5 Years)

Patents Prosecuted

Application numberTitle of the patentIPCFiling DateDecision Date
13829333 Methods of cell culture C12N, C07K, C12P Mar 13, 2013 Dec 21, 2015
13804069 METHODS FOR PREDICTING ANTI-INTEGRIN ANTIBODY RESPONSE C12Q Mar 13, 2013 Aug 1, 2016
13798204 ST2L antibody antagonists A61K, C07K, C12N Mar 12, 2013 Jul 27, 2015
13798226 ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions C07K, A61K Mar 12, 2013 Dec 14, 2015
13787173 Defined media for expansion and maintenance of pluripotent stem cells C12N Mar 5, 2013 Sep 5, 2016
13767292 Method for killing IL-1 alpha expressing cells C07K, A61K Feb 13, 2013 Jul 21, 2014
13765504 System and method for measuring an analyte in a sample and calculating hematocrit-insensitive glucose concentrations G01N Feb 11, 2013 Feb 15, 2016
13762453 Inhibiting cell migration A61K, C07K Feb 7, 2013 Mar 24, 2014
13739623 System and method for determining hematocrit insensitive glucose concentration C12Q, A61B, G01N Jan 10, 2013 Jul 13, 2015
13722869 Analytical test strip C12Q, G01N Dec 19, 2012 Oct 12, 2015
14363888 Anti-PHF-tau antibodies and their uses A61K, C07K Dec 18, 2012 Jun 20, 2016
13708369 Differentiation of human embryonic stem cells into single hormonal insulin positive cells C12N Dec 6, 2012 Jul 11, 2016
13679906 System and method for determination of a concentration of at least one interfering substance and correction of glucose concentration based on the concentration of the interfering substance G01N Nov 15, 2012 Jan 25, 2016
14354617 Therapeutic agents and uses thereof G01N, A61K, C07K Oct 25, 2012 May 23, 2016
13644976 Treatment of inflammatory skin disease A61K, A61P, C07K Oct 3, 2012 Aug 7, 2017
13630334 System and method for determining hematocrit insensitive glucose concentration G01N, A61B Sep 27, 2012 Apr 13, 2015
13628393 Fibronectin type III repeat based protein scaffolds with alternative binding surfaces C40B, C12N Sep 26, 2012 Nov 30, 2015
13628434 Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases C07K Sep 26, 2012 Jul 26, 2014
13625861 System and method for measuring an analyte in a sample and calculating glucose results to account for physical characteristics of the sample G01N Sep 23, 2012 Nov 14, 2016
13623144 Anti-tissue factor antibodies and compositions C12N, A61K, C07K, A61P Sep 19, 2012 Jul 17, 2017
Menu